Alligator Bioscience Eulerpool Ziņas

Alligator Bioscience Eulerpool News

Alligator Bioscience Akciju Ziņas

Alligator Bioscience tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Alligator Bioscience ziņas mēs apkopojam šeit.

• 11. jūlijs ·

  Yahoo
  Alligator Bioscience AB Reports Financial Results for H1 2024 and Q2 2024 and Provides a Business Update
• 26. jūnijs ·

  Yahoo
  Alligator Bioscience Announces Substantial Overall Survival Benefit and Unprecedented Duration of Response in the 18-Month Analysis from Mitazalimab OPTIMIZE-1 Phase 2 Study in 1st Line Pancreatic Cancer
• 25. jūnijs ·

  Yahoo
  Alligator Bioscience Announces Financing of Up to SEK 80 Million Extending Cash Runway to Q1 2025
• 3. jūnijs ·

  Yahoo
  Alligator Bioscience's Phase 2 mitazalimab Pancreatic Cancer Data Published in The Lancet Oncology
• 23. maijs ·

  Yahoo
  Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting
• 1. aprīlis ·

  Yahoo
  Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences
• 23. marts ·

  Yahoo
  Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg
• 11. februāris ·

  Yahoo
  Alligator Bioscience AB: Year End report January-December 2021
• 19. janvāris ·

  Yahoo
  Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty
• 18. janvāris ·

  Yahoo
  Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects Reported